AIM Schedule One - Totally PLC (9151S)
October 06 2017 - 3:00AM
UK Regulatory
TIDMTLY
RNS Number : 9151S
AIM
06 October 2017
ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT
PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2
OF THE AIM RULES FOR COMPANIES ("AIM RULES")
----------------------------------------------------------------------
COMPANY NAME:
----------------------------------------------------------------------
Totally plc
----------------------------------------------------------------------
COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT,
COMPANY TRADING ADDRESS (INCLUDING POSTCODES):
----------------------------------------------------------------------
Hamilton House
Mabledon Place
London
WC1H 9BB
United Kingdom
----------------------------------------------------------------------
COUNTRY OF INCORPORATION:
----------------------------------------------------------------------
England and Wales
----------------------------------------------------------------------
COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION
REQUIRED BY AIM RULE 26:
----------------------------------------------------------------------
http://www.totallyplc.com
----------------------------------------------------------------------
COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF
OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY,
DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION
IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER
UNDER RULE 14, THIS SHOULD BE STATED:
----------------------------------------------------------------------
Totally plc ("Totally" or the "Company") is
a provider of a range of out-of-hospital services
to the healthcare sector in the UK, both to
the NHS and the private sector, to help patients
access healthcare services quickly, to understand
healthcare options better to promote self-care
and to support the NHS to manage demand across
its services and to promote NHS policy of working
in partnership to deliver integrated services
aimed at keeping people out of hospital. The
Company achieves this principally through its
four existing business divisions and has a stated
'buy and build' strategy in the UK out-of-hospital
healthcare sector. The Company's main country
of operation is the UK.
The Company has conditionally agreed to acquire
the entire issued share capital of Vocare Limited
("Vocare") for a maximum consideration of GBP11
million on a cash free and debt free basis (the
"Acquisition"). The total consideration is being
satisfied through:
(i) the payment of GBP6.5 million in cash on
completion of the Acquisition, funded from the
Company's existing cash resources;
(ii) the issue of 7,306,889 new ordinary shares
at 47.9 pence per share to the vendors of Vocare
("Share Consideration"); and
(iii) deferred cash consideration of up to GBP1.0
million may be payable subject to the achievement
of an earn out based on the EBITDA of Vocare
for the year ended 31 March 2018.
Vocare is incorporated and registered in England
and Wales and is a provider of integrated urgent
care services to the NHS throughout the UK.
The services provided by Vocare include urgent
care centres, GP out-of-hours services, the
NHS 111 service and integrated urgent care services.
Other services provided include emergency dental
and pharmacy services. Vocare's main country
of operation is the UK.
Pursuant to Rule 14 of the AIM Rules for Companies,
the Acquisition constitutes a reverse takeover.
Shareholder approval for the Acquisition is
being sought at a general meeting convened for
23 October 2017.
----------------------------------------------------------------------
DETAILS OF SECURITIES TO BE ADMITTED INCLUDING
ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES
(i.e. where known, number and type of shares,
nominal value and issue price to which it seeks
admission and the number and type to be held
as treasury shares):
----------------------------------------------------------------------
59,795,172 ordinary shares of 10p each ("Ordinary
Shares") including 7,306,889 Ordinary Shares
to be issued at 47.9p per share on admission
to AIM pursuant to the Share Consideration.
No shares are held in treasury.
----------------------------------------------------------------------
CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE)
AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:
----------------------------------------------------------------------
Capital to be raised on Admission: N/A
Anticipated market capitalisation on Admission:
GBP28.70 million (based on the closing mid-market
share price on 21 July 2017)
----------------------------------------------------------------------
PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS
AT ADMISSION:
----------------------------------------------------------------------
15.04 per cent.
----------------------------------------------------------------------
DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM
TO WHICH THE AIM COMPANY HAS APPLIED OR AGREED
TO HAVE ANY OF ITS SECURITIES (INCLUDING ITS
AIM SECURITIES) ADMITTED OR TRADED:
----------------------------------------------------------------------
None
----------------------------------------------------------------------
FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED
DIRECTORS (underlining the first name by which
each is known or including any other name by
which each is known):
----------------------------------------------------------------------
Directors:
Robert (Bob) Holt Chairman
OBE
Wendy Jayne Lawrence Chief Executive Officer
Donald (Don) Ahelan Finance Director and
Baladasan Proposed Non-Executive
Director
Anthony (Tony) Rhys Non-Executive Director
Bourne
Michael (Mike) Greig Non-Executive Director
Rogers
Proposed Director:
Lisa Barter-Ng Proposed Finance Director
----------------------------------------------------------------------
FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS
EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE
CAPITAL, BEFORE AND AFTER ADMISSION (underlining
the first name by which each is known or including
any other name by which each is known):
----------------------------------------------------------------------
Before Admission After Admission
-------------------------- ------------------- ------------------
Shareholder Ordinary % Ordinary %
Shares Shares
-------------------------- ----------- ------ ----------- -----
Unicorn Asset Management
Limited 5,759,291 10.97 5,759,291 9.63
-------------------------- ----------- ------ ----------- -----
Lombard Odier Asset
Management (Europe)
Limited 5,450,000 10.38 5,450,000 9.11
-------------------------- ----------- ------ ----------- -----
Miton Asset Management
Limited 5,311,546 10.12 5,311,546 8.88
-------------------------- ----------- ------ ----------- -----
Legal & General Group
plc 4,900,000 9.34 4,900,000 8.19
-------------------------- ----------- ------ ----------- -----
Seneca Partners Limited 3,370,545 6.42 3,370,545 5.64
-------------------------- ----------- ------ ----------- -----
Killik & Co LLP 3,222,727 6.14 3,222,727 5.39
-------------------------- ----------- ------ ----------- -----
Threadneedle Asset
Management Limited 2,820,000 5.37 2,820,000 4.72
-------------------------- ----------- ------ ----------- -----
Royal London Asset
Management Limited 2,800,000 5.33 2,800,000 4.68
-------------------------- ----------- ------ ----------- -----
Schroder Investment
Management Limited 2,214,545 4.22 2,214,545 3.70
-------------------------- ----------- ------ ----------- -----
Canaccord Genuity
Group Inc 2,155,653 4.11 2,155,653 3.61
-------------------------- ----------- ------ ----------- -----
John Joseph Harrison - - 2,670,647 4.47
-------------------------- ----------- ------ ----------- -----
Michael Stephen Harrison - - 2,670,647 4.47
-------------------------- ----------- ------ ----------- -----
----------------------------------------------------------------------
NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE
WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:
----------------------------------------------------------------------
None
----------------------------------------------------------------------
(i) ANTICIPATED ACCOUNTING REFERENCE DATE
(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION
IN THE ADMISSION DOCUMENT HAS BEEN PREPARED
(this may be represented by unaudited interim
financial information)
(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST
THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:
----------------------------------------------------------------------
(i) 31 March
(ii) With respect to Totally, 30 June 2017 (unaudited
interim financial information)
With respect to Vocare, 31 March 2017 (audited
full year financial information)
(iii) 31 March 2018 (unaudited interim report
for the six months ended 31 December 2017)
30 September 2018 (annual report for the 15
month period ended 31 March 2018)
31 December 2018 (unaudited interim report
for the six months ended 30
September 2018)
----------------------------------------------------------------------
EXPECTED ADMISSION DATE:
----------------------------------------------------------------------
24 October 2017
----------------------------------------------------------------------
NAME AND ADDRESS OF NOMINATED ADVISER:
----------------------------------------------------------------------
Allenby Capital Limited
5 St. Helen's Place
London
EC3A 6AB
United Kingdom
----------------------------------------------------------------------
NAME AND ADDRESS OF BROKER:
----------------------------------------------------------------------
Allenby Capital Limited
5 St. Helen's Place
London
EC3A 6AB
United Kingdom
Cenkos Securities plc
6-8 Tokenhouse Yard
London
EC2R 7AS
United Kingdom
----------------------------------------------------------------------
OTHER THAN IN THE CASE OF A QUOTED APPLICANT,
DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS)
THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM,
WITH A STATEMENT THAT THIS WILL CONTAIN FULL
DETAILS ABOUT THE APPLICANT AND THE ADMISSION
OF ITS SECURITIES:
----------------------------------------------------------------------
Copies of the admission document, which will
contain full details about the Company and the
admission of its securities, will be available
from the registered office of the Company and
at the offices of Allenby Capital Limited, 5
St. Helen's Place, London EC3A 6AB during normal
business hours on any weekday (Saturdays, Sundays
and public holidays excepted) for a period of
one month from the date of admission.
The admission document will also be available
to download from the Company's website www.totallyplc.com
----------------------------------------------------------------------
DATE OF NOTIFICATION:
----------------------------------------------------------------------
6 October 2017
----------------------------------------------------------------------
NEW/ UPDATE:
----------------------------------------------------------------------
NEW
----------------------------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
PAAEAKEKELFXFEF
(END) Dow Jones Newswires
October 06, 2017 03:00 ET (07:00 GMT)
Totally (LSE:TLY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Totally (LSE:TLY)
Historical Stock Chart
From Sep 2023 to Sep 2024